AdvanSix (NYSE: ASIX) announced Q4 2025 earnings that delivered mixed results in a challenging chemical manufacturing environment.
Financial Results
AdvanSix Q4 2025 earnings revealed revenue of $359.9 million. This represents a 9.4% increase from $329.1 million in Q4 2024. The company navigated a mixed market with improved plant nutrient sales but continued weakness in nylon markets. In full year 2025, net income reached $49.3 million, up 11.8% from $44.1 million in 2024.
YoY Financial Comparison
| Metric | FY 2025 | FY 2024 | YoY Change |
| Revenue | $1,522.0M | $1,517.6M | +0.3% |
| Adjusted EBITDA | $156.8M | $142.1M | +10.4% |
| Net Income (GAAP) | $49.3M | $44.1M | +11.8% |
| Diluted EPS (GAAP) | $1.80 | $1.61 | +11.8% |
| Adjusted Diluted EPS | $2.28 | $2.06 | +10.7% |
| Operating Cash Flow | $122.9M | $110.4M | +11.3% |
| Free Cash Flow | $6.4M | $(5.9M) | Improved YoY |
EBITDA Performance Breakdown
Adjusted EBITDA for the full year 2025 totaled $156.8 million. This represents a 10.4% gain from $142.1 million in 2024. Adjusted EBITDA margin expanded to 10.3% from 9.4%, marking a 90 basis point improvement year-over-year.
Quarterly Revenue Trend Chart
Figure 1: AdvanSix Q4 2025 earnings quarterly revenue trend displays quarterly performance from Q4 2024 through Q4 2025.
Segment Performance Analysis
In 2025, AdvanSix Q4 earnings reflected diverse segment performance. Plant Nutrients delivered $563.7 million in revenue. Caprolactam generated $271.4 million. Nylon Solutions contributed $309.7 million amid an extended market cycle trough. Chemical Intermediates produced $377.5 million.
EBITDA Margin Trend
Figure 2: AdvanSix Q4 2025 earnings adjusted EBITDA margin trend illustrates margin progression across company quarters.
Outlook and Strategic Initiatives
Looking ahead to 2026, AdvanSix Q4 2025 earnings guidance indicates planned capital expenditures ranging from $75 million to $95 million. Plant turnaround expenses are estimated at $20 million to $25 million. The company expects to benefit from 45Q carbon capture tax credits and fixed cost reduction programs targeting $30 million in savings over multiple years.
Key Takeaways
- AdvanSix Q4 2025 earnings delivered $359.9M in revenue, up 9.4% vs. prior year quarter.
- Full-year 2025 adjusted EBITDA reached $156.8M, up 10.4%, with margin expansion to 10.3%.
- Plant Nutrients segment led growth with improved supply fundamentals.
- Extended nylon cycle trough continues to pressure chemical intermediates.
- 2026 guidance reflects reduced capital spending and strategic cost initiatives.
- Positive free cash flow generation supports shareholder returns.